BRIBF
Price
$0.24
Change
+$0.01 (+4.35%)
Updated
Aug 1 closing price
Capitalization
174.49M
HLVX
Price
$2.08
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
104.26M
69 days until earnings call
Interact to see
Advertisement

BRIBF vs HLVX

Header iconBRIBF vs HLVX Comparison
Open Charts BRIBF vs HLVXBanner chart's image
BRII BIOSCIENCE
Price$0.24
Change+$0.01 (+4.35%)
Volume$2.38K
Capitalization174.49M
HilleVax
Price$2.08
Change-$0.00 (-0.00%)
Volume$2.32M
Capitalization104.26M
BRIBF vs HLVX Comparison Chart in %
Loading...
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BRIBF vs. HLVX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRIBF is a Hold and HLVX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (BRIBF: $0.24 vs. HLVX: $2.08)
Brand notoriety: BRIBF and HLVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BRIBF: 33% vs. HLVX: 348%
Market capitalization -- BRIBF: $174.49M vs. HLVX: $104.26M
BRIBF [@Biotechnology] is valued at $174.49M. HLVX’s [@Biotechnology] market capitalization is $104.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRIBF’s FA Score shows that 0 FA rating(s) are green whileHLVX’s FA Score has 1 green FA rating(s).

  • BRIBF’s FA Score: 0 green, 5 red.
  • HLVX’s FA Score: 1 green, 4 red.
According to our system of comparison, HLVX is a better buy in the long-term than BRIBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRIBF’s TA Score shows that 4 TA indicator(s) are bullish while HLVX’s TA Score has 5 bullish TA indicator(s).

  • BRIBF’s TA Score: 4 bullish, 2 bearish.
  • HLVX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, HLVX is a better buy in the short-term than BRIBF.

Price Growth

BRIBF (@Biotechnology) experienced а 0.00% price change this week, while HLVX (@Biotechnology) price change was +0.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.15%. For the same industry, the average monthly price growth was +15.07%, and the average quarterly price growth was +29.12%.

Reported Earning Dates

HLVX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BRIBF($174M) has a higher market cap than HLVX($104M). BRIBF YTD gains are higher at: 91.790 vs. HLVX (0.483).
BRIBFHLVXBRIBF / HLVX
Capitalization174M104M167%
EBITDAN/A-66.58M-
Gain YTD91.7900.48319,000%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A160M-
Total DebtN/A23.5M-
TECHNICAL ANALYSIS
Technical Analysis
BRIBFHLVX
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 1 day ago
26%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
21%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
17%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
40%
Bearish Trend 1 day ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 16 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
BRIBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HLVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SPODF0.040.03
+223.39%
SPOD LITHIUM CORP.
CYSM14.70N/A
N/A
Community Bancorp of Santa Maria
KRYAF103.12N/A
N/A
Kerry Group plc
FGHQF0.15N/A
N/A
Frontage Hldgs Corp.
SDCVF63.03N/A
N/A
Sa des Ciments Vicat

BRIBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRIBF has been loosely correlated with HLVX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BRIBF jumps, then HLVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRIBF
1D Price
Change %
BRIBF100%
N/A
HLVX - BRIBF
55%
Loosely correlated
N/A
NRSN - BRIBF
6%
Poorly correlated
+1.79%
IMMX - BRIBF
6%
Poorly correlated
+16.84%
GNTA - BRIBF
5%
Poorly correlated
+0.66%
TELIF - BRIBF
2%
Poorly correlated
+2.04%
More

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been closely correlated with FBIOP. These tickers have moved in lockstep 81% of the time. This A.I.-generated data suggests there is a high statistical probability that if HLVX jumps, then FBIOP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
N/A
FBIOP - HLVX
81%
Closely correlated
+1.50%
BRIBF - HLVX
55%
Loosely correlated
N/A
DNLI - HLVX
49%
Loosely correlated
+0.32%
IPSC - HLVX
46%
Loosely correlated
-2.91%
NTLA - HLVX
45%
Loosely correlated
+1.58%
More